Daily Values

Others

Ratios

Asset Utilization Ratio Assets Average EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Inventory Average Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Invested Capital Return on Sales

LENZ Therapeutics (LENZ) Equity Average (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Equity Average for 2 consecutive years, with -$60.4 million as the latest value for Q3 2023.